Launching Excellence in a Post-Covid World
On September 16, AmCham Denmark, in partnership with IQVIA, hosted a virtual Healthcare Committee session on ‘Launching Excellence in a Post-Covid World’ with IQVIA VP and thought leader Sarah Rickwood.
The global pharmaceutical industry is changing, as is the environment for innovative product launches. The current covid-19 pandemic has put an increased focus and pressure on global business leaders in the life science industry to revisit their launch strategies and adapt to the new reality. But what makes launch excellence in a post-covid world?
Sarah Rickwood some of her key insights into achieving a successful launch as well the long-term trends driving the launch environment. In addition, she provided her latest perspectives on how the life science sector will evolve in the wake of the global pandemic and how these trends will challenge life science leadership.
- Download Sarah Rickwood’s presentation here.
- Read IQVIA white paper ‘Excellent Launches Are Winning the Evidence Battle’ here.
- Read IQVIA white paper ‘Launch Excellence in a Disrupted World: Challenges and Opportunity’ here.
About Sarah Rickwood
Sarah Rickwood has 28 years’ experience as a consultant to the pharmaceutical industry, having worked in Accenture’s pharmaceutical strategy practice prior to joining IQVIA. She has an extremely wide experience of international pharmaceutical industry issues, having worked for most of the world’s leading pharmaceutical companies on issues in the US, Europe, Japan, and leading emerging markets. She is now Vice President, European Marketing and Thought Leadership in IQVIA, a team she has run for 10 years. Sarah presents to hundreds of pharmaceutical industry clients every year on a wide range of global pharmaceutical industry issues, and has published multiple white papers on various topics within healthcare. Sarah Rickwood holds a degree in biochemistry from Oxford University.